9 Sarcoma Soft Tissue Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Sarcoma Soft Tissue Studies in New York

NCT06797999Recruiting

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

The goal of this clinical trial is to learn about the safety, tolerability and efficacy of ADCE-D01....

New York, NYPHASE1270 participantsAdcendo ApS

View Study Details

NCT05653388Recruiting

Metastatic Leiomyosarcoma Biomarker Protocol

Leiomyosarcoma (LMS) is one of the most prevalent soft tissue sarcomas (STS) and can occur in various sites including soft tissue, uterus and retroperitoneal large vessels. Metastatic disease occurs i...

New York, NY200 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

NCT04577014Recruiting

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

This study is being done to find out whether the study drug Retifanlimab, a monoclonal antibody against the PD-1 protein, combined with gemcitabine and docetaxel, is a safe and effective treatment for...

New York, NYPHASE198 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05551793Recruiting

Regeneron AA Multicenter (Dupilumab)

This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a total of 68 patients with moderate to severe AA (affe...

New York, NYPHASE276 participantsEmma Guttman

View Study Details

NCT05004987Recruiting

Aβ Dynamics in LLMD

This study will examine the biological factors that may modulate the relationship between depression and the development of Alzheimer's disease (AD). Since the direction of causation between depressio...

New York, NYPHASE460 participantsNYU Langone Health

View Study Details

NCT06843967Recruiting

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

The purpose of this study is to find out whether mirdametinib in combination with palbociclib is an effective and safe treatment for people with metastatic, recurrent, and unresectable liposarcoma. Th...

New York, NYPHASE154 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07156565Recruiting

Actinium Therapy for Late-stage Aggressive Sarcomas

The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio Therapeutics will learn if \[Ac225\]RTX-2...

New York, NYPHASE148 participantsRatio Therapeutics, Inc.

View Study Details

NCT05755113Recruiting

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

A Phase IIa open label study evaluating the preliminary efficacy of intratumoural tigilanol tiglate in advanced and/or metastatic soft tissue sarcoma of the extremities and body wall....

New York, NYPHASE240 participantsQBiotics Group Limited

View Study Details

NCT07516925Recruiting

A Study of Ivonescimab in People With Leiomyosarcoma

The purpose of this study is to find out if Ivonescimab is an effective and safe treatment that causes few or mild side effects for people with advanced/unresectable leiomyosarcoma....

New York, NYPHASE220 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Sarcoma Soft Tissue Clinical Trials in New York

Soft tissue sarcomas are rare cancers that develop in the soft tissues of the body including muscle, fat, blood vessels, and tendons. There are more than 50 subtypes, each with different characteristics. Treatment includes surgery, radiation, and chemotherapy, with newer targeted therapies under investigation.

There are currently 9 sarcoma soft tissue clinical trials recruiting participants in New York, NY. These studies are seeking a combined 866 participants. Research is being sponsored by Adcendo ApS, University of Michigan Rogel Cancer Center, Memorial Sloan Kettering Cancer Center and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sarcoma Soft Tissue Clinical Trials in New York — FAQ

Are there sarcoma soft tissue clinical trials in New York?

Yes, there are 9 sarcoma soft tissue clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What sarcoma soft tissue treatments are being tested?

The 9 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma soft tissue.

Data updated October 15, 2026 from ClinicalTrials.gov